Israel Innovation Authority

RepAir is at the forefront of advancing a carbon-negative future through its innovative carbon removal technology. The company has developed an electrochemical device that effectively captures carbon dioxide from the atmosphere by utilizing electricity. This process involves drawing in ambient air and passing it through a specialized membrane that selectively separates carbon dioxide, allowing clean air to be released back into the environment. RepAir's fully electric and zero-heat technology is designed for large-scale deployment, emphasizing environmental sustainability while minimizing energy consumption. Importantly, the system operates without the use of liquids, solvents, or hazardous materials, producing no waste and supporting clients in reducing their carbon footprints and energy costs.

Brain.space is a data company focused on brain mapping, aiming to support researchers, medical professionals, and software developers in interpreting and analyzing brain activity. The company offers a comprehensive and affordable technology stack that includes noninvasive brain activity mapping and monitoring, along with validated big data interpretation and insights. This platform enables users to develop innovative products and services that leverage brain activity data, facilitating advancements in various fields related to neuroscience and mental health.

We're Building the Next Big Thing

nT-Tao is building a compact fusion reactor that will generate 10-20 MW of electricity. The reactor is highly scalable and will be about the size of a shipping container, ensuring clean fusion energy wherever needed. The reactor’s scalability and affordability will make it suitable for various power needs, ranging from industrial and manufacturing facilities to small towns and off-grid locations. This scalability coupled with the ability for rapid deployment, positions nT-Tao’s reactor as a versatile and adaptable fusion energy solution. nT-Tao’s unique solution relies on a proprietary plasma heating method which is expected to reach 1000 times higher density than other fusion reactors, thereby making its fusion reaction 1 million times more effective. nT-Tao’s ability for quick development iterations and its groundbreaking approach, dramatically reduces the size, cost, and complexity of fusion energy reactors. Co-founded by Oded Gour-Lavie, Doron Weinfeld, and Boaz Weinfeld, nT-Tao’s mission is to develop a unique nuclear fusion technology that will enable the world to transition towards a cleaner, decarbonized, sustainable, and advanced future.

IBI-Ag is a biotechnology company dedicated to developing innovative bioinsecticides that provide environmentally friendly pest management solutions for farmers. The company focuses on creating natural single-domain antibody insecticides designed to enhance crop production while ensuring the safety of farm workers, consumers, and the environment. By utilizing advanced technology and fermentation processes, IBI-Ag offers efficient and selective pest control solutions that lower agricultural costs. The company's platform is built on thorough testing and extensive learning, allowing farmers to access customized biological pest control strategies that meet their specific needs. Through its commitment to sustainable practices, IBI-Ag aims to revolutionize the agricultural landscape by promoting safer and more effective methods of insect management.

Lowental Hybrid specializes in developing hybrid propulsion systems for Unmanned Aerial Vehicles (UAVs). Their technology combines fuel-based propulsion with electric power, enabling UAVs to operate for longer durations while maintaining the low noise levels characteristic of electric systems. The company's advanced parallel hybrid solution, comprising an electric motor and an internal combustion engine, allows UAVs to achieve vertical take-off using electricity and extend flight times up to fivefold, maximizing power, efficiency, and reliability for diverse missions.

Promise Bio is a biotechnology company dedicated to advancing precision medicine for autoimmune diseases. It leverages epiproteomic analysis, a cutting-edge technique that examines protein modifications, to gain insights into disease mechanisms. The company's core technology is a cloud-based AI platform that processes standard mass-spectrometry data, enabling comprehensive analysis and discovery of biomarkers. This innovative approach aims to optimize personalized treatment plans, enhance the quality of care, and make chronic disease management more affordable and effective.

MICA is a medical technology company focused on improving breast cancer diagnosis through artificial intelligence. It has developed a system that aids radiologists in the analysis and comparison of mammography images. By offering a range of products designed for mammogram analysis, image comparison, and medical records management, MICA aims to enhance the accuracy of breast cancer detection. The company's tools enable medical professionals to facilitate early diagnosis and treatment, ultimately contributing to a reduction in breast cancer incidence.

i-EcoGuard specializes in sustainable agriculture, utilizing advanced nanoparticle technology to enhance greenhouse efficiency. The company's core product is an innovative, self-adapting polymer that optimizes greenhouse conditions, promoting plant health, improving crop quality, and boosting energy efficiency.

Airobotics offers a fully automated solution for collecting aerial data, catering to government, industrial, and commercial sectors. The company manufactures autonomous unmanned aerial drones that facilitate automated data capture and analysis. Airobotics' technology is utilized for a variety of applications, including real-time video monitoring, disaster assessments, compliance audits, land investigations, inspections, surveillance, progress tracking, and survey services. By providing these comprehensive capabilities, Airobotics enables organizations to gain valuable insights and improve operational efficiency.

Eretz Angels supports technology startups in Israel's outskirts at the start of their journey.

Lidwave is a developer of advanced 3D sensing technology that addresses significant challenges in traditional LiDAR and radar systems. By utilizing a novel approach based on finite coherence ranging, Lidwave's solution offers four-dimensional sensing capabilities that enhance automation across various sectors, including autonomous vehicles, industrial robotics, and smart cities. The technology leverages new coherent properties of light, providing superior Doppler and depth information that improves decision-making processes. This innovative approach not only overcomes the limitations of existing sensing methods but also positions Lidwave as a leader in the development of disruptive sensing technologies, paving the way for smarter and safer applications in numerous industries.

Lavie Bio specializes in the development of bacterial compositions and microbiome-based products aimed at enhancing agricultural practices. The company's offerings include bio-stimulants and bio-pesticides that can be applied as sprays on plants, used to coat seeds, or integrated into soil. These products are designed to improve the quality and health attributes of crops by utilizing natural, biological sources, including various microbial and biochemical components. Lavie Bio focuses on providing agricultural businesses with innovative ag-biological technologies to support sustainable farming and improve plant features.

Pickommerce is revolutionizing e-commerce logistics with its autonomous pick-and-pack robotic system, PickoBot. This innovative solution addresses labor constraints in the growing e-commerce sector by streamlining the picking and packing process. PickoBot's advanced computer vision system, powered by machine learning, allows it to handle a vast array of items with various grippers and packing algorithms. This adaptable technology seamlessly integrates into both automated and conventional warehouses, minimizing disruption while boosting efficiency and productivity. Pickommerce's patented adhesive picking methods and AI-driven decision-making algorithms ensure optimal grasp configuration and package box optimization.

SolidT is at the forefront of innovation, pioneering a cutting-edge decentralized temperature control system based on solid-state technology. This revolutionary system empowers precise regulation of temperature for various components, such as batteries, battery cells, modules, high-frequency processors, displays, interiors, and more – all achieved without the need for traditional compressors and their associated systems. SolidT's groundbreaking technology promises to streamline automotive temperature control systems by simplifying complexity, shedding excess weight, and enhancing reliability. This innovation not only elevates efficiency and precision but also significantly slashes manufacturing costs and operational expenses. SolidT's disruptive system finds applications across diverse industries, including automotive, electronics, and high-energy devices, making it a game-changer for temperature management solutions.

TruLeaf Medical is a developer of user-friendly Transcatheter Mitral Valve Replacement (TMVR) solution.

IR-MED Ltd. is a medical device company based in Rosh Pinna, Israel, specializing in infrared light-based diagnostic systems. Founded in 2012, the company utilizes advanced technologies such as big data and machine learning to enhance its diagnostic capabilities. IR-MED focuses on developing continuous and real-time monitoring systems that can detect and measure various substances and pharmaceuticals in the blood. Additionally, its technology allows for the assessment of fluid concentrations on surfaces and beneath thin tissues, facilitating the identification and characterization of diverse medical lesions and pathological processes in humans.

OCON Healthcare, also known as OCON Medical Ltd., specializes in developing and manufacturing innovative women's health products centered around its proprietary Intra Uterine Ball (IUB) platform. Key offerings include the IUB Ballerine, a hormone-free, copper-based intrauterine contraceptive effective for five years, and the OCON SEAD, which is currently undergoing Phase II clinical studies for treating abnormal uterine bleeding. The IUB platform, constructed from a super-elastic alloy, serves as an effective carrier for various therapeutic substances targeting conditions such as heavy menstrual bleeding, fibroids, and infertility. The company distributes its contraceptive products primarily in Europe, South Africa, and Israel. Founded in 2011, OCON Healthcare operates from its headquarters in Modi'in-Maccabim-Re'ut, Israel, and maintains an additional office in Zürich, Switzerland.

Eight Two Hundred Angels is an investment firm, They assist in promoting the companies in which they invest, attract investors, and qualify investors interested in investing in innovative technologies and high-risk investments.

TEClub VC is an investment firm for mega angels that invests in breakthrough technologies at early stages through a smart and selective investment platform. They focus on creating unicorn companies and venture creation models.

Nugen Clean Energy specializes in off-grid electric vehicle (EV) charging systems. Their innovative technology uses a solid-state hydrogen compound to safely generate and utilize hydrogen on-site and on-demand, ensuring a reliable and sustainable power source even in remote locations. This enhances grid capacity and provides uninterrupted charging, making EV charging infrastructure more scalable and dependable.

Qualifire is a real-time safety and quality control platform for LLM-based applications, enabling enterprises to deploy reliable, compliant, and trustworthy AI solutions. Qualifire intercepts and blocks inaccuracies, hallucinations, and policy violations in real time, safeguarding brand integrity and regulatory compliance. Qualifire supports the entire AI lifecycle from training and experimentation to deployment and oversight. Qualifire integrates seamlessly into any workflow, ensuring that AI outputs consistently align with organizational standards and strategic objectives. It empowers teams to confidently deploy AI that adheres to business and regulatory requirements, accelerating time-to-market while protecting against the risks of AI unpredictability.

AccuLine is a digital healthcare company focused on preventing heart attacks by offering innovative solutions for early detection of coronary artery disease (CAD). The company is developing CORA, a non-invasive examination technology that provides a smart, accurate, and user-friendly alternative to traditional stress tests. By streamlining the detection process, CORA enables healthcare providers to identify CAD more swiftly and cost-effectively, ultimately aiming to save millions of lives worldwide through timely intervention.

Soltell specializes in Industrial IoT-powered automation for the management of rooftop solar photovoltaic (PV) systems. The company's smart solar management platform allows for cost-effective supervision of distributed solar energy fleets, connecting solar service providers, commercial property owners, and smart city initiatives. Utilizing advanced process automation and proprietary sensorless weather measurement technology, Soltell enhances transparency and efficiency in the operation of rooftop solar PV installations. Its platform is designed to support a range of inverters and data loggers, making it compatible with both new and existing PV systems. By offering predictive maintenance capabilities, Soltell aids clients in optimizing the management and operation of decentralized solar energy systems, ultimately facilitating a transition to more resilient and efficient energy generation in urban settings.

Sequentify is a biotechnology company that develops innovative solutions for targeted DNA sequencing applications, including cancer diagnostics, carrier screening, and COVID-19 surveillance. By integrating synthetic biology with artificial intelligence software, the company offers alternative library-preparation methods that facilitate rapid and cost-effective genome sequencing. This technology empowers researchers to conduct genomic diagnostics and therapeutics on a large scale, thus enhancing the efficiency and accessibility of genomic analysis in various health-related fields.

FireDome's revolutionary wildfire defense system takes a two-tiered strategy. First, a mechanical launcher quickly deploys a protective barrier to impede the direct route of advancing wildfires. Second, the system actively detects and promptly extinguishes spot fires created by airborne embers that bypass the primary barrier.

Charging Robotics engages in wireless charging solutions.

NurExone Biologic is developing a biological exosome based technology drug platform to treat damage in the Central Nerve System.

Airobotics offers a fully automated solution for collecting aerial data, catering to government, industrial, and commercial sectors. The company manufactures autonomous unmanned aerial drones that facilitate automated data capture and analysis. Airobotics' technology is utilized for a variety of applications, including real-time video monitoring, disaster assessments, compliance audits, land investigations, inspections, surveillance, progress tracking, and survey services. By providing these comprehensive capabilities, Airobotics enables organizations to gain valuable insights and improve operational efficiency.

CODA is a cloud-based AI platform that translates spoken language into sign language and provides the deaf community with easier access to video content in their preferred language.

Maris-Tech is a global leader in video and AI-based edge computing technology, pioneering intelligent video transmission solutions that conquer complex encoding-decoding challenges. Our miniature, lightweight, and low-power products deliver high-performance capabilities including raw data processing, seamless transfer, advanced image processing, and AI-driven analytics. Founded by Israel technology sector veterans, Maris-Tech serves leading manufacturers worldwide in defense, aerospace, Intelligence gathering, homeland security (HLS) and communication industries worldwide. We’re pushing the boundaries of video transmission and edge computing, driving innovation in mission-critical applications across commercial and defense sectors.

Microbot Medical is a medical device company based in Hingham, Massachusetts, founded in 2010. It specializes in developing micro-robotic technologies for minimally invasive surgery. The company's key products include the Self Cleaning Shunt (SCS) for treating hydrocephalus and normal pressure hydrocephalus, TipCAT, a self-propelling endoscope initially designed for colonoscopy procedures, and Liberty, a combination of guidewire and microcatheter technologies for endoluminal surgery. Microbot Medical aims to enhance surgical outcomes by providing less invasive and more precise solutions, with 37 issued/allowed patents and 15 patent applications pending worldwide.

Pashoot Robotics specializes in contextual robotics for the manufacturing sector, focusing on the flexible deployment of robotic arms. The company has developed automation software that allows robots to learn and adapt to their environments, moving beyond simple pre-programmed tasks. This innovative approach democratizes robotic automation, enabling manufacturers to enhance productivity and maintain competitiveness in their respective industries. By integrating human-like learning capabilities into production lines, Pashoot Robotics aims to transform traditional manufacturing practices and improve operational efficiency.

SolidT is at the forefront of innovation, pioneering a cutting-edge decentralized temperature control system based on solid-state technology. This revolutionary system empowers precise regulation of temperature for various components, such as batteries, battery cells, modules, high-frequency processors, displays, interiors, and more – all achieved without the need for traditional compressors and their associated systems. SolidT's groundbreaking technology promises to streamline automotive temperature control systems by simplifying complexity, shedding excess weight, and enhancing reliability. This innovation not only elevates efficiency and precision but also significantly slashes manufacturing costs and operational expenses. SolidT's disruptive system finds applications across diverse industries, including automotive, electronics, and high-energy devices, making it a game-changer for temperature management solutions.

EMRIS Pharma takes care of the life and treatment compliance for cancer patients.

BloomX is an AI pollination solution for crops in which pollination is a limiting factor for their yield. The company allows growers to increase their revenue by enlarging yields in existing crops and improving fruit quality. BloomX's vision is to provide an AI-based pollination solution that addresses each crop’s pollination needs by mimicking the natural pollination process and enhancing it using technology. Bumblebee was founded in 2019 and is headquartered in Tel Aviv, Israel.

MICA is a medical technology company focused on improving breast cancer diagnosis through artificial intelligence. It has developed a system that aids radiologists in the analysis and comparison of mammography images. By offering a range of products designed for mammogram analysis, image comparison, and medical records management, MICA aims to enhance the accuracy of breast cancer detection. The company's tools enable medical professionals to facilitate early diagnosis and treatment, ultimately contributing to a reduction in breast cancer incidence.

UB Therapeutics is a biotechnology company developing a novel therapy for the treatment of multiple myeloma.

Atiko Labs specializes in creating innovative robotic solutions to address various challenges in agriculture, focusing on farming autonomy. The company designs and develops smart, custom-made robots that function like farmers, aiming to enhance efficiency and productivity in the agricultural sector. Additionally, Atiko Labs has developed a portable optical sensor capable of detecting materials or contaminants in production line samples. This technology provides rapid, high-resolution detection with accurate results delivered within seconds. The data collected is securely stored and analyzed in the cloud, allowing clients to identify target molecules on-site, thereby streamlining quality control processes in their operations.

NINA Medical is focused on advancing non-invasive surgical innovations aimed at improving patient outcomes. The company has developed an image-guided, noninvasive treatment system that targets Benign Prostatic Hyperplasia (BPH), a condition affecting many men. This diagnostic-therapeutic approach allows for treatment in office settings, significantly reducing post-operative complications such as bleeding, infections, and pain. NINA Medical's core technology enables practitioners to visualize the high-intensity focused ultrasound (HIFU) beam in real-time, providing distinct advantages over traditional minimally invasive procedures. By widening the reach of next-generation medicine, NINA Medical aims to enhance the overall patient experience and outcomes in prostate treatment.

Oversight is a developer of a 3D collaborative workspace platform aimed at enhancing decision-making for first responders. The platform integrates advanced AI simulation and real-time data management from various devices, including drones, body cameras, and smartphones. By providing comprehensive situational awareness, Oversight supports emergency response teams in their mission planning and operational efficiency, enabling them to make informed decisions during critical situations.

DioTree is a biotechnology company specializing in the development of innovative treatments for high-grade serous ovarian cancer (HGSOC). The company's core focus is to inhibit the enzyme DIO3, which plays a significant role in driving ovarian cancer progression, by utilizing a novel mechanism of action and small molecule technology. DioTree aims to advance cancer treatment, improve patient outcomes, and positively impact the lives of those affected by this disease.

Enzymit is focused on transforming global manufacturing by advancing cell-free bio-production technology, which aims to reduce reliance on scarce resources and enhance sustainability. The company develops novel enzymes using artificial intelligence and deep learning algorithms, enabling the creation of innovative molecular machines that can convert abundant feedstocks into valuable products across various sectors, including pharmaceuticals, cosmetics, food, and materials. By employing small, modular bio-reactors, Enzymit enhances efficiency, reduces costs, and minimizes environmental impact compared to traditional whole-cell bio-production methods. This approach not only fosters resource independence but also allows for greater flexibility in product customization, positioning Enzymit as a competitive alternative to conventional chemical manufacturing.

Navina is a technology company that has developed an AI-driven platform aimed at transforming disorganized patient data into clear and actionable patient portraits. This innovative approach allows physicians to quickly assess complex cases, significantly enhancing the diagnostic process and patient care. By utilizing artificial intelligence and machine learning, Navina's platform organizes essential patient information in a way that is intuitively accessible, ensuring that critical data is easily understood and contextually relevant. This capability not only improves patient wellness but also supports better financial outcomes for healthcare providers and payers. Additionally, Navina collaborates with the American Academy of Family Physicians Innovation Lab, further solidifying its commitment to advancing healthcare through technology.

BioBetter is a foodtech company founded in 2015 and based in Israel, specializing in the development of plant-based platforms for the production of complex growth factors essential for cultivated meat. The company focuses on leveraging the advantages of plants as bioreactors for protein expression by utilizing transgenic plants that co-express therapeutic proteins alongside enzymes that eliminate antigenic sugars. This innovative approach simplifies the manufacturing and purification of proteins and biological drugs, allowing biotech professionals to lower production costs effectively.

VRee AI develops state of the art 3D technologies based on AI methods such as NeRF and deep learning, to generate 3D models for AR/VR environments. We basically help turning 2D images into 3D models in the blink of an AI.

SuperMeat is an Israeli biotech and food-tech company founded in 2015 and based in Tel Aviv. It specializes in producing cultured meat from chicken cells in a safe, controlled environment, eliminating the need for animal slaughter. This innovative approach to meat production aims to enhance nutritional security and reduce carbon emissions. By growing meat in a sterile setting, SuperMeat ensures that its products are free from antibiotics and the risk of fecal contamination, such as salmonella. The company emphasizes sustainability, as its clean meat production requires significantly fewer resources—99% less land and 90% less water—compared to traditional methods. SuperMeat aspires to transform the meat industry, offering a healthier and more sustainable food source for the future.

VALFIX Medical Ltd, established in 2016 and based in Tel Aviv, Israel, specializes in the design and development of transcatheter solutions for Mitral and Tricuspid valve repair and replacement. Their innovative, minimally-invasive approach combines repair and replacement treatments, providing a viable alternative to open-heart surgery. The company's multi-wire technology enables transcatheter mitral valve repair procedures, aiming to alleviate heart failure symptoms and treat various heart conditions by eliminating mitral regurgitation.

Brevel has developed an innovative cultivation technology focused on the sustainable and cost-effective production of microalgae. Utilizing high-tech, fully automated indoor systems that feature internal illumination, Brevel's approach achieves significant cost reductions and substantially higher yields compared to traditional methods. This advanced technology positions the company to tap into various markets in need of microalgae-derived products, including sustainable food, materials, chemicals, pharmaceuticals, and energy. By unlocking the full potential of microalgae, Brevel aims to create an alternative protein source suitable for mass production, addressing the increasing demand for environmentally friendly solutions across multiple industries.

Enlivex Therapeutics Ltd. is a clinical-stage immunotherapy company headquartered in Nes Ziona, Israel, focused on developing allogeneic drugs aimed at rebalancing the immune system. The company's lead product, Allocetra, is an immunotherapy candidate currently undergoing multiple clinical trials. These include a Phase IIb trial for severe sepsis, an investigator-initiated Phase II trial for COVID-19 patients in severe and critical conditions, and a Phase IIa trial for preventing Graft Versus Host Disease in patients undergoing allogeneic hematopoietic stem cell transplants. Additionally, Enlivex is exploring Allocetra's potential in preventing complications from bone marrow transplants and acute multiple organ failure. The company also aims to develop cell-based therapies that enhance the efficacy of treatments for solid tumors through immune checkpoint rebalancing. Founded in 2005 by Professor Dror Mevorach, Enlivex utilizes a novel approach that focuses on inducing immune tolerance by employing apoptotic cells to modulate inflammatory and autoimmune responses.

Olive Diagnostics has developed an innovative passive urine analysis sensor that can be mounted on any toilet, enabling continuous health monitoring through urinalysis. This sensor utilizes a combination of spectroscopy and artificial intelligence to analyze the urine stream and provide real-time health alerts to users. By uploading data to a cloud-based platform, Olive Diagnostics facilitates ongoing biomarker tracking for various health indicators such as hydration, alcohol levels, pregnancy, and ovulation. This technology not only empowers individuals to gain insights into their health and body functions but also offers pharmaceutical and clinical research organizations a reliable method to monitor drug compliance and usage. By making urine lab services accessible at home, Olive Diagnostics aims to enhance disease detection and chronic disease management, particularly benefiting users in nonindustrial nations.

Gemma is focused on revolutionizing the makeup experience for women by developing an automatic makeup application machine. This innovative device simplifies the process of applying makeup, enabling users to achieve various looks in under two minutes using automated airbrush technology and real-time color mixing. Gemma's patented technology empowers women to select their desired makeup look, essentially providing the benefits of a professional makeup artist in the comfort of their own homes. By streamlining makeup application, Gemma aims to enhance the confidence and convenience for busy individuals seeking a quick and effective beauty solution.

Cybord specializes in technologies designed to prevent counterfeit, defective, and malicious electronic components from being used in manufacturing. The company employs artificial intelligence and a comprehensive global database to analyze each electronic component before it is placed in a product. By integrating its system with manufacturing equipment, Cybord provides real-time assessments and traceability for components, combining material inspection and documentation to ensure authenticity and quality. This proactive approach addresses a significant issue in the electronics industry, where counterfeit components account for 5 to 10% of all parts, leading to substantial return merchandise authorizations. By enhancing product quality and securing supply chains, Cybord enables original equipment manufacturers, electronics manufacturing services, and distributors to mitigate risks associated with hardware-cyber threats.

AccuLine is a digital healthcare company focused on preventing heart attacks by offering innovative solutions for early detection of coronary artery disease (CAD). The company is developing CORA, a non-invasive examination technology that provides a smart, accurate, and user-friendly alternative to traditional stress tests. By streamlining the detection process, CORA enables healthcare providers to identify CAD more swiftly and cost-effectively, ultimately aiming to save millions of lives worldwide through timely intervention.

DermaDetect is a developer of an AI-driven digital dermatology platform designed to diagnose and manage skin, hair, and nail conditions. The platform allows patients to conduct self-assessments and analyze non-pigmented skin lesions and acute diseases from anywhere, facilitating remote diagnosis. By automatically detecting skin issues and recommending treatments, DermaDetect enhances access to dermatological care. Additionally, it connects patients with nearby physicians for further assistance, making it easier for individuals to receive timely and effective care for skin disorders from the comfort of their homes.

DermaDetect is a developer of an AI-driven digital dermatology platform designed to diagnose and manage skin, hair, and nail conditions. The platform allows patients to conduct self-assessments and analyze non-pigmented skin lesions and acute diseases from anywhere, facilitating remote diagnosis. By automatically detecting skin issues and recommending treatments, DermaDetect enhances access to dermatological care. Additionally, it connects patients with nearby physicians for further assistance, making it easier for individuals to receive timely and effective care for skin disorders from the comfort of their homes.

Alumor develops solar-powered water purification technology devices based on ultraviolet LED light which can purify any type of surface water, including lakes, rivers, lagoons, and pools.

MagniLearn is an AI-focused startup that specializes in delivering personalized educational experiences to students. The company has developed a platform that leverages artificial intelligence and natural language processing to create tailored lessons based on individual student progress. This innovative system not only generates lessons that are appropriate for each learner but also provides real-time feedback by identifying errors and suggesting subsequent topics for instruction. By emphasizing data-driven approaches, MagniLearn aims to enhance learning efficiency and support students in achieving language proficiency through personalized instruction.

Precision Ag-Biosecurity Data Platform For Livestock Farming.

BeeHero is a company that has developed an innovative beehive technology platform aimed at enhancing crop yields through effective pollination. Utilizing artificial intelligence and machine learning algorithms, the platform employs low-cost sensors to gather data from within beehives. This information helps stimulate optimal productivity during critical pollination periods, assisting farmers in safeguarding their beehives against colony collapse and improving overall pollination efficiency. Founded in 2017 by Itai Kanot, Omer Davidi, and Yuval Regev, BeeHero operates from locations in Tel Aviv and Silicon Valley, with a workforce of 50 employees, including 30 at its research and development center in Israel.

Kipp enables card issuers and merchants to approve more transactions, leading to higher customer satisfaction and greater revenue. Kipp's platform serves and supports issuer banks in optimizing their cards' business, leveraging their relationships with merchants, their willingness to share data and participate in the cost of risk.

Silib is a battery manufacturing company focused on developing innovative silicon anodes for lithium-ion batteries. These anodes enhance battery capacity by over 40%, achieving energy densities exceeding 1000Wh/L. Silib's unique manufacturing process allows for the creation of pure silicon anodes in a straightforward, single-stage method, eliminating the need for catalysts, precious metals, or binders. This design makes the anodes compatible with any cell format, serving as a direct replacement for traditional graphite-based anodes. By utilizing nanostructured silicon and a cost-effective, high-mass loading approach, Silib enables clients to reduce battery size while maintaining or enhancing energy content.

Ripe Guard is a technology company focused on developing a platform that predicts the shelf life of fruits and vegetables. Its objective is to address the significant waste and depreciation within the $2.3 trillion fresh produce industry, where up to 45% of produce is often discarded. By providing accurate predictions of when fruits and vegetables will ripen and spoil, Ripe Guard's system aims to enhance efficiencies throughout the supply chain. This technology not only helps food producers minimize waste but also optimizes the management of fresh produce, ultimately contributing to a more sustainable and economically viable fruit and vegetable sector.

Tiktalk To Me owns and operates a digital health company intended to offer a platform for speech therapy. Its platform functions as a virtual speech therapist, guiding patients through proven and widely accepted training protocols using online games supervised by the patient's personal speech therapist and combines gaming with speech- and voice-recognition technology, enabling speech-language pathologists to shorten the treatment cycle and save substantial time and money for the patients.

Growee specializes in innovative hydroponics technology that allows home gardeners and urban farmers to effortlessly monitor and manage their systems through a smartphone application. Its electronic hydroponic device automates critical functions, including pH balance, temperature control, and nutrient distribution, enabling users to cultivate fresh, organic produce indoors or in urban settings. This technology not only enhances convenience but also promotes sustainability by significantly reducing nutrition costs, conserving water, and minimizing carbon emissions. Growee's advanced analytics and real-time sensing capabilities provide users with insights to optimize crop rotation and yields, making it suitable for growers of all experience levels. The company's solutions are designed to foster resource efficiency and support a greener lifestyle, ultimately transforming small-scale farming into a more efficient and enjoyable endeavor.

Mush Foods is a New York-based food technology company specializing in the production of edible mushroom mycelium as a sustainable protein alternative. Their flagship product line, 50CUT, is unique in its ability to blend seamlessly with real animal meat, significantly reducing the carbon footprint associated with traditional meat production. By utilizing fermentation and artificial intelligence, Mush Foods efficiently creates fungi-based ingredients that enhance the nutrition, taste, and cost-effectiveness of plant-based dishes. This innovative approach positions the company at the forefront of the growing demand for sustainable and animal-free protein sources.

IBI-Ag is a biotechnology company dedicated to developing innovative bioinsecticides that provide environmentally friendly pest management solutions for farmers. The company focuses on creating natural single-domain antibody insecticides designed to enhance crop production while ensuring the safety of farm workers, consumers, and the environment. By utilizing advanced technology and fermentation processes, IBI-Ag offers efficient and selective pest control solutions that lower agricultural costs. The company's platform is built on thorough testing and extensive learning, allowing farmers to access customized biological pest control strategies that meet their specific needs. Through its commitment to sustainable practices, IBI-Ag aims to revolutionize the agricultural landscape by promoting safer and more effective methods of insect management.

ViAqua Therapeutics Ltd is an Israeli company founded in 2014 that specializes in developing innovative drugs and therapeutics for the aquaculture industry. The company focuses on creating the first orally administered treatment designed to combat viral diseases affecting aquatic species, particularly shrimp. ViAqua's proprietary platform employs a unique RNAi nanoparticle formulation that triggers a cellular response to disable viral infections. This technology enables the delivery of coated nanoparticles through feed or immersion techniques, enhancing the resistance of aquaculture species against viral epidemics. With a management team experienced in business development and industrial biotechnology, ViAqua aims to improve the health and sustainability of aquaculture practices.

Ark Surgical is a medical device start-up focused on enhancing laparoscopic surgery through innovative solutions. The company has developed LapBox, a containment system designed to safely remove large internal organs via a laparoscopic keyhole incision. This device significantly reduces the risk of cancerous tissue dispersion during minimally invasive procedures, particularly in women's health. The first version of LapBox has received FDA clearance, with a second iteration in development. By enabling surgeons to perform safe organ removals without the complications associated with traditional tissue morcellation, Ark Surgical aims to improve patient outcomes in laparoscopic surgeries.

CorrActions is a technology company that specializes in a software-based platform designed to enhance human-machine interaction. This platform focuses on detecting, decoding, and transforming human brain signals to minimize errors in real-time. By leveraging artificial intelligence, CorrActions enables machines to better understand human behavior and improve learning efficiency. The applications of this technology span various industries, including aviation, automotive, medical, and technology, aiming to revolutionize the efficiency of both humans and machines through advanced brain-computer interface solutions.

Enlivex Therapeutics Ltd. is a clinical-stage immunotherapy company headquartered in Nes Ziona, Israel, focused on developing allogeneic drugs aimed at rebalancing the immune system. The company's lead product, Allocetra, is an immunotherapy candidate currently undergoing multiple clinical trials. These include a Phase IIb trial for severe sepsis, an investigator-initiated Phase II trial for COVID-19 patients in severe and critical conditions, and a Phase IIa trial for preventing Graft Versus Host Disease in patients undergoing allogeneic hematopoietic stem cell transplants. Additionally, Enlivex is exploring Allocetra's potential in preventing complications from bone marrow transplants and acute multiple organ failure. The company also aims to develop cell-based therapies that enhance the efficacy of treatments for solid tumors through immune checkpoint rebalancing. Founded in 2005 by Professor Dror Mevorach, Enlivex utilizes a novel approach that focuses on inducing immune tolerance by employing apoptotic cells to modulate inflammatory and autoimmune responses.

Skip Therapeutics specializes in developing RNA-based precision treatments aimed at addressing rare genetic diseases. Millions of individuals globally suffer from various rare genetic disorders, but the unique nature of these conditions, often defined by specific mutations, presents challenges in discovering effective therapies. The company utilizes splice-modulating antisense oligonucleotides (ASOs) to analyze mutation data at scale, facilitating the identification of treatable patient cohorts and optimizing therapeutic designs. By leveraging recent advancements in RNA therapeutics and computational techniques, Skip Therapeutics can match innovative molecular strategies to restore protein function, thereby enhancing treatment accessibility and effectiveness for affected individuals.

Aqualitas specializes in developing a modular water quality monitoring system that operates continuously and requires minimal maintenance. Their platform allows customers to select specific physicochemical parameters for monitoring, while the system utilizes self-diagnosis and automated processes to streamline operations. By leveraging Internet of Things (IoT) technology, Aqualitas collects real-time water quality data, which is analyzed and transformed into actionable insights delivered to users through a software-as-a-service (SaaS) platform. This approach eliminates the need for an initial investment in equipment, enabling customers to expand their monitoring capabilities as their needs grow. Aqualitas's use of artificial intelligence and machine learning further enhances the system by ensuring sensor operational stability and automatic calibration, ultimately resulting in lower costs and improved efficiency for industries reliant on accurate water quality data.

Spectalix provides a unique solution for brands looking to regain user engagement on their own digital platforms, such as apps and websites, by offering a white-label user-generated content (UGC) platform. This innovative platform utilizes advanced AI video technology, including background replacement and image segmentation, which allows users to create personalized video content featuring themselves in various scenes, such as alongside sports teams or popular musicians. By enabling users to share these clips on social media, Spectalix transforms them into micro-influencers, helping brands enhance their digital presence. Additionally, the platform incorporates an automated moderation mechanism to ensure brand safety of the content created. This approach allows brands to monetize their digital assets while fostering a deeper connection with their audience.

ZygoFix is a medical device company focused on spine technology. It has developed a three-dimensional printed implant designed to lock the facet joint of the lumbar spine. This innovative device leverages the anatomy of the spine to provide stability, moving away from traditional external screw-based systems. By eliminating the need for pedicle screws, ZygoFix aims to reduce the risks associated with improper screw placement, enhancing patient safety and outcomes in spinal surgeries.

Anicca is a health technology company specializing in mental well-being. It designs and develops a wearable device equipped with a respiration sensor and haptic feedback mechanism. This device, worn on the wrist, monitors and analyzes the user's breathing patterns, providing real-time, gentle vibrations to help regulate stress levels, improve focus, and enhance sleep quality.

Flytrex is the largest drone-based food delivery service in the United States, primarily operating in North Carolina and Texas. The company has successfully fulfilled over 120,000 orders for various partners, including notable chains such as Little Caesars, Papa John's, and El Pollo Loco. Flytrex's service is designed to offer rapid delivery, reducing costs from $10 to $1 per package and cutting delivery times from 20 minutes to under 5. With a strong customer retention rate of 45% after two years and a household penetration of 70% within its service range, the company has garnered significant customer satisfaction, reflected in its high Net Promoter Score of 75. Flytrex employs advanced automated drone technology operated via a cloud-based control system, facilitating efficient deliveries even to hard-to-reach areas while minimizing operational expenses for retailers and delivery companies.

FertilAI is a healthcare company focused on enhancing fertility treatment outcomes through advanced technology. The company has developed an AI-driven platform that streamlines the decision-making process for physicians, thereby improving the success rate of fertility treatments. Its algorithms are integrated into the Fertilane platform, which facilitates efficient communication among clinics, doctors, and patients via specialized applications designed for fertility workflows. Founded by a team of technology experts and leading reproductive endocrinologists in Israel, FertilAI aims to elevate the patient experience and enable clinics to scale their operations effectively.

ThermoTerra captures a new source of renewable energy, powered by natural fluctuations in humidity - Humidity Power - to heat and cool build.

Enzymit is focused on transforming global manufacturing by advancing cell-free bio-production technology, which aims to reduce reliance on scarce resources and enhance sustainability. The company develops novel enzymes using artificial intelligence and deep learning algorithms, enabling the creation of innovative molecular machines that can convert abundant feedstocks into valuable products across various sectors, including pharmaceuticals, cosmetics, food, and materials. By employing small, modular bio-reactors, Enzymit enhances efficiency, reduces costs, and minimizes environmental impact compared to traditional whole-cell bio-production methods. This approach not only fosters resource independence but also allows for greater flexibility in product customization, positioning Enzymit as a competitive alternative to conventional chemical manufacturing.

Phytolon Ltd, founded in 2000 and based in Misgav, Israel, specializes in the development of natural food colorants. The company has established a novel and sustainable technology that utilizes fermentation processes with baker’s yeast cells as biofactories to produce high-quality, plant-based food colors. This innovative approach provides a healthy alternative to synthetic food dyes, offering food manufacturers safe, cost-effective, and stable all-natural colors. Phytolon is dedicated to promoting human health and environmental sustainability through scientific advancement in the food color industry.

High Lander provides a software solution that transforms off-the-shelf drones into pilot-less units, facilitating the creation of coordinated, autonomous fleets. Its Mission Control platform enables users to manage various drones effectively, addressing challenges such as short battery life by integrating features for building and administering commercial drone airports. This capability allows users to recharge drones and dispatch them as needed, making High Lander's technology suitable for diverse applications, including first response, robotic aerial security, and precision agriculture. The company aims to maximize the potential of commercial drones across various missions.

Vessi Medical is an Israeli medical device startup focused on innovating treatment for Non-Muscle-Invasive Bladder Cancer (NMIBC) through a novel surface cryotherapy approach. This method employs extreme cold to freeze and eliminate abnormal tissue, addressing the limitations of traditional first-line therapies like TransUrethral Resection of Bladder Tumor (TURBT), which can be invasive, costly, and often result in cancer recurrence. Vessi's technology offers a minimally invasive, office-based therapy that reduces the need for hospital stays and repeat surgeries, which are common in conventional treatments. The system comprises a standalone console and a disposable catheter that allows for targeted cell destruction while safeguarding healthy bladder tissue. Vessi Medical, supported by the Trendlines Group and led by experienced professionals in the medical device and cryotherapy fields, has already shown promising results in animal studies. The company's initial focus is on the $1.2 billion NMIBC market, with plans to expand into treatment options for overactive bladder and urinary tract infections in the future.

Soltell specializes in Industrial IoT-powered automation for the management of rooftop solar photovoltaic (PV) systems. The company's smart solar management platform allows for cost-effective supervision of distributed solar energy fleets, connecting solar service providers, commercial property owners, and smart city initiatives. Utilizing advanced process automation and proprietary sensorless weather measurement technology, Soltell enhances transparency and efficiency in the operation of rooftop solar PV installations. Its platform is designed to support a range of inverters and data loggers, making it compatible with both new and existing PV systems. By offering predictive maintenance capabilities, Soltell aids clients in optimizing the management and operation of decentralized solar energy systems, ultimately facilitating a transition to more resilient and efficient energy generation in urban settings.

RFISee is focused on developing advanced radar technology aimed at enhancing the safety and functionality of autonomous vehicles, drones, and robots. The company is creating the world's first 4D imaging radar on a single chip, which features high-resolution, low-cost radar sensors. These sensors are capable of generating real-time 3D location and velocity maps of surrounding objects, thereby facilitating greater automation in driving. RFISee's innovative approach is set to disrupt the transportation industry by enabling safer vehicles and introducing new business models. The technology is particularly well-suited for the autonomous car market, which is experiencing rapid growth, as radar systems are reliable in various weather and lighting conditions, making them a preferred choice in military and defense applications.

Magentiq Eye Ltd. is a medical device company based in Haifa, Israel, established in 2014. It specializes in developing advanced technologies for endoscopic procedures, particularly focusing on automatic polyp detection during colonoscopies. The company's flagship product, the Automatic Polyp Detection System (APDS), leverages deep learning and computer vision to enhance the accuracy of polyp identification, thereby reducing the miss rate during examinations. The APDS is available in two formats: APDS-RT, which operates in real-time by processing video feeds from endoscopic cameras, and APDS-OFL, which analyzes pre-recorded colonoscopy videos. Given the prevalence of colonoscopies—approximately 40 million performed annually—the system aims to improve patient outcomes by increasing detection rates and minimizing the risk of interval cancers. Magentiq Eye's technology not only supports physicians in making more informed decisions during procedures but also has the potential for integration with existing endoscopic equipment or as a service model for clinics and hospitals.

90 days from launch (Dec 20): - 4 paying clients in 90 days, 25 days sales cycle. - 10,000 users covering all 10 largest cities of Israel. Together with our SafeUPer we - Create a Safe World for Women - One community at a time. Create – We believe people must take an action, getting out of our comfort zone, to achieve this change. Sharing stories is simply not enough. Safe – We believe being safe is a basic right of all women, and like all women right achieved by previous generations, it will be gained with sweat and tears. World – We are facing a global problem, documented for at least two millennia (2,000 yrs), maybe the only problem impacting women daily, of all ages, countries, backgrounds and beliefs. Therefore. We believe it should be solved globally, empowering women all around the world to bring safety to their local communities. Women – We believe that when women will have peace, men too will have peace. Men have proven that they are unable to bring peace and safety by themselves to themselves nor to women. Therefore, we need to lead and bring it together.

Baseline Vision specializes in providing a scalable real-time game analytics solution tailored for the net-sports market, with an initial focus on tennis. The company's platform leverages a portable smart-camera device to deliver a range of digital products, including line-calling, performance tracking, on-court gamification, and video feedback. This innovative approach enables tennis players and coaches to analyze past training sessions, monitor their progress, connect with other players, and share their experiences on social media, enhancing their overall training and competitive experience.

DiA Imaging Analysis Ltd. specializes in AI-driven ultrasound analysis technology aimed at enhancing cardiac function diagnostics. Established in 2009 and based in Beersheba, Israel, the company provides a suite of automated tools, including LVivo EF for ejection fraction evaluation, LVivo RV for right ventricle analysis, and LVivo Strain for assessing myocardial strain. These solutions address common challenges faced by clinicians, such as obtaining optimal images and accurately analyzing them for clinical abnormalities. DiA's products, which can be integrated into any ultrasound device or healthcare IT system, also include LVivo SAX for detecting coronary heart disease and LVivo Mobile for mobile ultrasound analysis. The company holds regulatory clearances for its cardiac toolbox and serves a global user base, reflecting its commitment to making ultrasound analysis smarter and more accessible.

XRHealth Ltd. is a medical technology company based in Tel Aviv, Israel, that specializes in developing virtual reality (VR) software solutions for healthcare. Founded in 2016, the company offers an array of products designed to enhance patient care and treatment outcomes. Its offerings include VRPhysio, a platform for virtual physical therapy; VRReliever, which helps manage pain through distraction; VRCogni, aimed at improving motor function in stroke and dementia patients; and VRPsyc, which provides exposure therapy for various mental health disorders. Additionally, VRCoordi is designed to aid coordination recovery in patients with Parkinson's, brain injuries, and autism. By integrating immersive technologies with licensed clinicians and advanced data analytics, XRHealth provides comprehensive telehealth services, allowing patients to access treatment from the comfort of their own homes.

Caaresys develops advanced vehicle passenger monitoring systems aimed at preventing vehicle-related tragedies. The technology utilizes a contactless low-emission radio frequency radar to detect passenger presence, positioning, and vital signs, including heart rate and respiratory rate. When a potential danger is identified, it sends alerts to a paired mobile device and activates the car alarm. Caaresys has secured significant partnerships with leading suppliers like Infineon, SMK, and Ficosa to facilitate large-scale deployment of its solutions. The company has entered into a licensing agreement for two million units with a major European OEM and has engaged in various projects across multiple sectors, including automotive and health. Its initiatives include a child detection system for school buses and active projects focused on vital signs monitoring in medical settings, highlighting its commitment to enhancing safety and health through innovative technology.

Cymptom provides a security platform designed to proactively measure and manage cyber risk by identifying and mapping potential attack paths before they occur. The platform utilizes agentless data collection technology to continuously visualize viable attack scenarios across both on-premises and cloud environments. By aligning its risk assessment with the MITRE ATT&CK® framework, Cymptom enables organizations to understand and prioritize security gaps in real-time without the need for simulations or interference with existing security measures. This approach offers simple deployment and immediate insights, ensuring continuous cyber resilience and enabling organizations to safeguard their mission-critical assets without disrupting business operations.

Enlivex Therapeutics Ltd. is a clinical-stage immunotherapy company headquartered in Nes Ziona, Israel, focused on developing allogeneic drugs aimed at rebalancing the immune system. The company's lead product, Allocetra, is an immunotherapy candidate currently undergoing multiple clinical trials. These include a Phase IIb trial for severe sepsis, an investigator-initiated Phase II trial for COVID-19 patients in severe and critical conditions, and a Phase IIa trial for preventing Graft Versus Host Disease in patients undergoing allogeneic hematopoietic stem cell transplants. Additionally, Enlivex is exploring Allocetra's potential in preventing complications from bone marrow transplants and acute multiple organ failure. The company also aims to develop cell-based therapies that enhance the efficacy of treatments for solid tumors through immune checkpoint rebalancing. Founded in 2005 by Professor Dror Mevorach, Enlivex utilizes a novel approach that focuses on inducing immune tolerance by employing apoptotic cells to modulate inflammatory and autoimmune responses.

Nobio Ltd. is an Israel-based company that specializes in developing innovative nano-polymer additives designed to protect against microbial infections. Their technology offers a unique, fully-integrated anti-biofilm solution, utilizing potent particles embedded in various materials and products to inhibit biofilm formation indefinitely. Nobio's product line includes a universal bonding agent that provides strong adhesion for dental applications, as well as flowable composites suitable for various restorative procedures. By transforming both implantable and non-implantable devices into biofilm-resistant platforms, Nobio aims to enhance the safety and durability of medical and dental materials through its advanced antimicrobial technology.

AgroScout Ltd. is an Israeli company established in 2017 that specializes in developing an artificial intelligence-based platform aimed at enhancing sustainable farming practices. The company's technology provides precision agriculture solutions by utilizing advanced analytics and high-resolution aerial imagery to assess crop health and monitor for pests and diseases. AgroScout's platform supports farmers by offering insights on crop emergence, stand counts, canopy coverage, and biomass throughout the growing season. This continuous monitoring allows for early detection of infestations, enabling more effective curative treatments and reducing pesticide use. By delivering actionable insights into crop management and regional outbreak predictions, AgroScout aims to improve crop yields and profitability while fostering a more sustainable food production supply chain.

BrainStorm Cell Therapeutics Inc. is a biotechnology company focused on developing and commercializing adult stem cell therapies for neurodegenerative diseases. Their proprietary technology, NurOwn, utilizes a patient's own mesenchymal stem cells, which are engineered to produce neurotrophic factors that promote neuronal survival. The company is actively advancing NurOwn through clinical trials for conditions such as amyotrophic lateral sclerosis (ALS), multiple sclerosis (MS), and Parkinson's disease. Currently, NurOwn is in a Phase III clinical trial for ALS and a Phase II trial for MS, with plans for preclinical studies targeting Parkinson’s disease, Huntington’s disease, and autism spectrum disorder. BrainStorm has partnered with Catalent for the manufacturing of NurOwn, ensuring the production of this autologous cellular therapy. Founded in 2000 and headquartered in New York, BrainStorm Cell Therapeutics was previously known as Golden Hand Resources Inc. before rebranding in 2004.

Aquafit Intimate is a pioneer in the field of intimate wellness. Our mission is to empower women to take control of their intimate wellness through self-care, for women of all ages. - An ask anything AI companion for personalised gynae wellness self assessments and getting help. - Our flagship Intimate Gel Stick family, which combines vaginal muscle training with the delivery of natural extracts to help restore elasticity, hydration, and pH balance for pain-free intimacy. Our products and services address very common intimate wellness conditions, central to women's health and wellbeing.

Indoor Robotics Ltd, founded in 2018 and based in Ramat Gan, Israel, specializes in the design and development of Tando, an AI-powered patrol drone tailored for indoor security and inspection tasks. Tando employs independent AI-based navigation and a patented ceiling docking system, providing real-time coverage and utilizing predictive analysis to reduce false alarms. The drone autonomously collects and analyzes data, promoting consistent quality and enhancing safety. This innovative solution combines robotics with advanced AI capabilities, offering a cost-effective and efficient approach to intelligent indoor monitoring. By collaborating with leaders in the security and smart building sectors, Indoor Robotics aims to transform the landscape of indoor surveillance and inspection through improved area coverage and response times.

Brevel has developed an innovative cultivation technology focused on the sustainable and cost-effective production of microalgae. Utilizing high-tech, fully automated indoor systems that feature internal illumination, Brevel's approach achieves significant cost reductions and substantially higher yields compared to traditional methods. This advanced technology positions the company to tap into various markets in need of microalgae-derived products, including sustainable food, materials, chemicals, pharmaceuticals, and energy. By unlocking the full potential of microalgae, Brevel aims to create an alternative protein source suitable for mass production, addressing the increasing demand for environmentally friendly solutions across multiple industries.

TaTiO specializes in enhancing recruitment processes through its innovative virtual job simulation application. By utilizing AI-based simulations, TaTiO allows candidates to immerse themselves in a realistic job experience, fostering an emotional connection to the role. This approach not only screens candidates based on their actual skills but also effectively matches them with suitable job opportunities. As a result, businesses can optimize their recruitment strategies, improving both the speed and quality of hiring. The platform significantly increases application and engagement rates while reducing drop-off rates, ensuring that companies attract candidates who are genuinely interested and engaged with their organization.